ATE532777T1 - Substituierte chromanderivate, medikamente und anwendungen in der therapie - Google Patents

Substituierte chromanderivate, medikamente und anwendungen in der therapie

Info

Publication number
ATE532777T1
ATE532777T1 AT05779877T AT05779877T ATE532777T1 AT E532777 T1 ATE532777 T1 AT E532777T1 AT 05779877 T AT05779877 T AT 05779877T AT 05779877 T AT05779877 T AT 05779877T AT E532777 T1 ATE532777 T1 AT E532777T1
Authority
AT
Austria
Prior art keywords
derivatives
chromeder
medications
therapy
substituted
Prior art date
Application number
AT05779877T
Other languages
English (en)
Inventor
Andrew Heaton
Alan James Husband
Original Assignee
Marshall Edwards Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/AU2004/001619 external-priority patent/WO2005049008A1/en
Priority claimed from AU2005201855A external-priority patent/AU2005201855B2/en
Application filed by Marshall Edwards Inc filed Critical Marshall Edwards Inc
Application granted granted Critical
Publication of ATE532777T1 publication Critical patent/ATE532777T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/34—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only
    • C07D311/38—2,3-Dihydro derivatives, e.g. isoflavanones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT05779877T 2004-09-21 2005-09-21 Substituierte chromanderivate, medikamente und anwendungen in der therapie ATE532777T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US61130004P 2004-09-21 2004-09-21
PCT/AU2004/001619 WO2005049008A1 (en) 2003-11-19 2004-11-19 Combinational radiotherapy and chemotherapy compositions and methods
AU2005201855A AU2005201855B2 (en) 2004-09-21 2005-05-03 Chroman derived compounds and formulations thereof for use in therapy
PCT/AU2005/001435 WO2006032085A1 (en) 2004-09-21 2005-09-21 Substituted chroman derivatives, medicaments and use in therapy

Publications (1)

Publication Number Publication Date
ATE532777T1 true ATE532777T1 (de) 2011-11-15

Family

ID=36089770

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05779877T ATE532777T1 (de) 2004-09-21 2005-09-21 Substituierte chromanderivate, medikamente und anwendungen in der therapie

Country Status (11)

Country Link
US (6) US7601855B2 (de)
EP (2) EP2407462B1 (de)
CN (1) CN101056868B (de)
AT (1) ATE532777T1 (de)
AU (1) AU2005287865B2 (de)
CA (1) CA2581316C (de)
IL (1) IL182034A (de)
MX (1) MX2007003216A (de)
NO (1) NO20072004L (de)
NZ (1) NZ553834A (de)
WO (1) WO2006032085A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE532777T1 (de) 2004-09-21 2011-11-15 Marshall Edwards Inc Substituierte chromanderivate, medikamente und anwendungen in der therapie
US8080675B2 (en) 2004-09-21 2011-12-20 Marshall Edwards, Inc. Chroman derivatives, medicaments and use in therapy
CN101203219B (zh) * 2005-03-24 2011-06-15 诺沃根研究控股有限公司 消炎用药程式
US20100173983A1 (en) * 2007-03-16 2010-07-08 David Brown Method for inducing autophagy
EP2334296A4 (de) * 2008-08-29 2012-04-25 Novogen Res Pty Ltd Immunmodulierende aktivitäten
US9663484B2 (en) 2010-11-01 2017-05-30 Mei Pharma, Inc. Isoflavonoid compounds and methods for the treatment of cancer
US20120251630A1 (en) * 2011-03-29 2012-10-04 Marshall Edwards, Inc. Remission therapy of cancer with isoflavonoids
US8911935B2 (en) 2011-10-17 2014-12-16 New York University Mitochondria and human immunodefiency virus type 1
KR101459195B1 (ko) 2012-12-28 2014-11-07 경기대학교 산학협력단 항암 활성을 갖는 4-니트로알킬크로만 유도체, 이의 제조방법 및 이를 포함하는 약학 조성물
MY195739A (en) 2014-02-07 2023-02-08 Novogen ltd Functionalised Benzopyran Compounds and use Thereof
EP3253208B1 (de) 2015-02-02 2021-05-05 MEI Pharma, Inc. Kombinationstherapien zur verwendung bei der behandlung von brustkrebs
WO2017173498A1 (en) 2016-04-06 2017-10-12 Noxopharm Limited Isoflavonoid composition with improved pharmacokinetics
CA3058492A1 (en) * 2016-04-06 2017-10-12 Noxopharm Limited Radiotherapy improvements
AU2021247415A1 (en) 2020-03-30 2022-09-29 Noxopharm Limited Methods for the treatment of inflammation associated with infection
WO2023090829A1 (ko) * 2021-11-17 2023-05-25 엘젠테라퓨틱스 주식회사 Mll1-wdr5 상호작용을 조절하는 저분자 화합물 및 이의 용도
WO2024232597A1 (ko) * 2023-05-10 2024-11-14 엘젠테라퓨틱스 주식회사 Wdr5를 분해하는 4-크로만온 화합물 및 이의 용도
CN118005595B (zh) * 2023-05-24 2024-10-29 内蒙古大学 具有烯丙醇结构色满衍生物的合成及抗肿瘤活性

Family Cites Families (88)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3340276A (en) 1964-04-01 1967-09-05 Ciba Geigy Corp 3, 4-diphenyl-chromans
DE1518002C3 (de) 1965-01-02 1975-01-23 Merck Patent Gmbh, 6100 Darmstadt Isoflavane und Isoflavene und Verfahren zu Ihrer Herstellung sowie diese enthaltende Arzneimittel
DE1543749A1 (de) 1966-02-16 1969-12-11 Merck Ag E Verfahren zur Herstellung von 3,4-cis-4-Aryl-isoflavanen
GB1433013A (de) 1973-06-08 1976-04-22
US4218489A (en) 1977-06-08 1980-08-19 Z-L Limited Partnership Antioxidants, antioxidant compositions and methods of preparing and using same
US4264509A (en) 1977-06-08 1981-04-28 Z-L Limited Partnership Isoflavones and related compounds, methods of preparing and using and antioxidant compositions containing same
US4157984A (en) 1977-06-08 1979-06-12 Z-L Limited Antioxidants, antioxidant compositions and methods of preparing and using same
US4232122A (en) 1979-01-17 1980-11-04 Z-L Limited Partnership Antioxidants, antioxidant compositions and methods of preparing and using same
US4234577A (en) 1979-03-19 1980-11-18 Z-L Limited Partnership Ergostadientriols, compositions containing same, and methods of preparing and using same
US4368264A (en) 1979-03-19 1983-01-11 Z-L Limited Partnership Fermentation methods of preparing ergostadientriols
US4366082A (en) 1979-04-11 1982-12-28 Z-L Limited Partnership Isoflavones and related compounds, methods of preparing and using and antioxidant compositions containing same
US4366248A (en) 1979-04-11 1982-12-28 Z-L Limited Partnership Fermentation method of preparing antioxidants
US4390559A (en) 1979-04-11 1983-06-28 Z-L Limited Partnership Isoflavones and related compounds, methods of preparing and using and antioxidant compositions containing same
US4447622A (en) 1981-09-22 1984-05-08 Council Of Scientific And Industrial Research Rafi Marg Preparation of l- and d-isomers of dl-3,4-trans-2,2-disubstituted-3,4-diarylchromans and derivatives thereof
US4644012A (en) 1983-12-21 1987-02-17 Takeda Chemical Industries, Ltd. Treatment for osteoporosis
GB8626344D0 (en) 1986-11-04 1986-12-03 Zyma Sa Bicyclic compounds
US5059609A (en) 1987-10-19 1991-10-22 Pfizer Inc. Substituted tetralins, chromans and related compounds in the treatment of asthma, arthritis and related diseases
MX13485A (es) 1987-10-19 1993-05-01 Pfizer Procedimiento para obtener tetralinas, cromados y compuestos relacionados, sustituidos
KR0166088B1 (ko) 1990-01-23 1999-01-15 . 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
DE69023906T2 (de) 1990-08-09 1996-04-11 Council Scient Ind Res Benzopyrane und Verfahren zu deren Herstellung.
PL308473A1 (en) 1992-10-21 1995-08-07 Pfizer Enabntiomeric cis-3-(4,6-dihydoxychroman-3-yl methyl)bezoic acids
US5280040A (en) 1993-03-11 1994-01-18 Zymogenetics, Inc. Methods for reducing bone loss using centchroman derivatives
US5451603A (en) 1993-03-11 1995-09-19 Zymogenetics, Inc. 3,4-diarylchromans for treatment of dermatitis
US5389646A (en) 1993-12-30 1995-02-14 Zymogenetics, Inc. Methods for treatment and prevention of bone loss using 2,3-benzopyrans
US5792776A (en) 1994-06-27 1998-08-11 Cytomed, Inc., Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
CZ212397A3 (en) 1995-01-13 1997-11-12 Novo Nordisk As Use of 3,4-diphenylchromans for preparing pharmaceutical preparations for treating or prophylaxis of hyperlipoproteinaemia, hypertriacylglycerolaemia, hyperlipidaemia, hypercholesterolaemia, arteriosclerosis and reduction of blood sedimentation
HUP9702244A3 (en) 1995-01-13 1999-12-28 Novo Nordisk As Use of 3,4-diphenyl chromans for manufacture of a pharmaceutical composition for treatment or prophylaxis of gynaecological disorders
CA2208868A1 (en) 1995-01-13 1996-07-18 Novo Nordisk A/S Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of idiopathic or physiologic gynaecomastia
TW448046B (en) 1995-01-20 2001-08-01 Novo Nordisk As Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of obesity
JPH10513154A (ja) 1995-01-20 1998-12-15 ノボ ノルディスク アクティーゼルスカブ 血管拡張治療または予防用の医薬組成物の製造への３，４−ジフェニルクロマンの使用
CZ212097A3 (en) 1995-01-20 1997-11-12 Novo Nordisk As Use of 3,4-diphenylchromans for preparing a medicament intended for treating or prophylaxis of cerebral degenerative diseases
US5849461A (en) 1995-08-01 1998-12-15 Shin-Etsu Chemical Co., Ltd. Chemically amplified positive resist composition
JP2000506505A (ja) 1996-01-11 2000-05-30 ノボ ノルディスク アクティーゼルスカブ 閉経期の症状の治療又は予防のための医薬組成物の製造のための３，４―ジフェニルクロマンの使用
US5726202A (en) 1996-01-11 1998-03-10 Novo Nordisk A/S Benign prostatic hypertrophy
US5883118A (en) 1996-01-11 1999-03-16 Nova Nordisk A/S Prostatic carcinoma
US5747059A (en) 1996-01-11 1998-05-05 Novo Nordisk A/S Atrophy of skin/mucous membrane
US5756539A (en) 1996-07-11 1998-05-26 Novo Nordis A/S 3, 4-diphenyl chromans for inhibiting one or more psychiatric disorders
WO1998002154A1 (en) 1996-07-12 1998-01-22 Novo Nordisk A/S Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for inhibiting one or more symptoms of premenstrual syndrome
US5780502A (en) * 1996-07-12 1998-07-14 Novo Nordisk A/S Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for inhibiting one or more symptoms of premenstrual syndrome
JP2000514443A (ja) 1996-07-12 2000-10-31 ノボ ノルディスク アクティーゼルスカブ 眼内圧を下げるための医薬組成物の製造のための３，４―ジフェニルクロマンの使用
AUPO203996A0 (en) 1996-08-30 1996-09-26 Novogen Research Pty Ltd Therapeutic uses
GB9621757D0 (en) 1996-10-18 1996-12-11 Ciba Geigy Ag Phenyl-substituted bicyclic heterocyclyl derivatives and their use
US5985306A (en) * 1996-10-28 1999-11-16 Novo Nordisk A/S (+)-enantiomers of cis-3,4-chroman derivatives useful in prevention or treatment of estrogen diseases or syndromes
ZA979642B (en) * 1996-10-28 1998-04-28 Novo Nordisk As Heterocyclic compounds, compositions and uses.
US5919817A (en) * 1996-10-28 1999-07-06 Novo Nordisk A/S Cis-3, 4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
US6316494B1 (en) * 1996-10-28 2001-11-13 Novo Nordisk A/S cis3, 4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
ZA979646B (en) 1996-10-28 1998-04-28 Novo Nordisk As Heterocyclic compounds, compositions and uses.
WO1998018774A1 (en) 1996-10-28 1998-05-07 Novo Nordisk A/S Novel trans-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
JP2001502711A (ja) 1996-10-28 2001-02-27 ノボ ノルディスク アクティーゼルスカブ エストロゲン関連疾患又は症候群の予防又は治療において有用な新規のシス―３、４―クロマン誘導体
ZA979649B (en) 1996-10-28 1998-04-28 Novo Nordisk As Heterocyclic compounds, compositions and uses.
US6043269A (en) * 1996-10-28 2000-03-28 Novo Nordisk A/S cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
ZA979644B (en) 1996-10-28 1998-04-28 Novo Nordisk As Heterocyclic compounds, compositions and uses.
ZA979647B (en) 1996-10-28 1998-04-28 Novo Nordisk As Heterocyclic compounds, compositions and uses.
US5958967A (en) 1996-10-28 1999-09-28 Novo Nordisk A/S Cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
IL129625A0 (en) 1996-10-28 2000-02-29 Novo Nordisk As Novel (-)-enantionmers of CIS-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
US5994390A (en) 1996-10-28 1999-11-30 Novo Nordisk Trans-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
JP2001502703A (ja) 1996-10-28 2001-02-27 ノボ ノルディスク アクティーゼルスカブ （−）―３，４―トランス―ジアリールクロマンの調製方法
US6153768A (en) * 1996-12-13 2000-11-28 C & C Research Laboratories Benzopyran derivatives
AU5550298A (en) 1997-01-29 1998-08-25 Novo Nordisk A/S Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical compositionfor increasing libido in post-menopausal women
AU5550398A (en) 1997-01-29 1998-08-25 Novo Nordisk A/S Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical compositionfor inhibiting senescence-associated motor impairment
ZA98682B (en) 1997-01-29 1998-07-29 Novo Nordisk As Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for inhibiting one or more psychiatric disorders
WO1999049862A1 (en) 1998-03-30 1999-10-07 The University Of Mississippi Isoflavones for treating giardiasis and malaria
WO1999055898A1 (en) 1998-04-28 1999-11-04 Novo Nordisk A/S Enzymatic resolvation for obtaining a (-)-3,4-trans-diarylchroman
FR2778404B1 (fr) 1998-05-06 2000-06-30 Hoechst Marion Roussel Inc Derives du dihydro ou tetrahydronaphtalene, et les compositions pharmaceutiques les renfermant
US6465445B1 (en) 1998-06-11 2002-10-15 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
KR20000001793A (ko) * 1998-06-13 2000-01-15 이경하 신규한 벤조피란 또는 티오벤조피란 유도체
AUPP868599A0 (en) 1999-02-15 1999-03-11 Novogen Research Pty Ltd Production of isoflavone derivatives
AUPQ008299A0 (en) 1999-04-30 1999-05-27 G.J. Consultants Pty Ltd Isoflavone metabolites
AUPQ266199A0 (en) 1999-09-06 1999-09-30 Novogen Research Pty Ltd Compositions and therapeutic methods involving isoflavones and analogues thereof
AU7896100A (en) 1999-10-14 2001-04-23 Endorecherche Inc. Selective estrogen receptor modulators in the treatment or reduction of the riskof acquiring hypertension, cardiovascular diseases, and insulin resistance
AU1888001A (en) 1999-12-13 2001-06-18 Chugai Seiyaku Kabushiki Kaisha Optically active chroman and thiochroman derivatives
HUP0204211A3 (en) 2000-01-28 2005-06-28 Endorech Inc Sainte Foy Selective estrogen receptor modulators in combination with estrogens and pharmaceutical compositions containing them
FI20001593A7 (fi) 2000-07-03 2002-01-04 Orion Yhtymo Oyj Comt-entsyymiõ inhiboivaa aktiivisuutta omaavia kumariinijohdannaisia
WO2002059113A1 (en) * 2001-01-24 2002-08-01 Chiesi Farmaceutici S.P.A. 2h-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof
WO2003016270A2 (en) 2001-08-11 2003-02-27 Bristol-Myers Squibb Pharma Company Selective estrogen receptor modulators
AUPR846401A0 (en) 2001-10-25 2001-11-15 Novogen Research Pty Ltd 6-Hydroxy isoflavones, derivatives and medicaments involving same
JP2005524630A (ja) * 2002-01-14 2005-08-18 ノルディック・ビオサイエンス・エー／エス エストロゲン受容体を介する軟骨破壊の抑制
CN1646119A (zh) 2002-04-09 2005-07-27 诺沃根研究有限公司 涉及异黄－3－烯和异黄烷结构的治疗方法和组合物
AU2002951833A0 (en) 2002-10-02 2002-10-24 Novogen Research Pty Ltd Compositions and therapeutic methods invloving platinum complexes
US20060167037A1 (en) * 2003-11-19 2006-07-27 Kelly Graham E Combinational radiotherapy and chemotherapy compositions and methods
EP2436680B1 (de) 2004-09-21 2016-05-18 Marshall Edwards, Inc. Chromanderivate, Medikamente und Anwendung in der Therapie
US8080675B2 (en) 2004-09-21 2011-12-20 Marshall Edwards, Inc. Chroman derivatives, medicaments and use in therapy
JP4976649B2 (ja) 2004-09-21 2012-07-18 マーシャル エドワーズ，インク． 化合物
ATE532777T1 (de) 2004-09-21 2011-11-15 Marshall Edwards Inc Substituierte chromanderivate, medikamente und anwendungen in der therapie
US20100173983A1 (en) 2007-03-16 2010-07-08 David Brown Method for inducing autophagy
EP2334296A4 (de) 2008-08-29 2012-04-25 Novogen Res Pty Ltd Immunmodulierende aktivitäten
US9663484B2 (en) 2010-11-01 2017-05-30 Mei Pharma, Inc. Isoflavonoid compounds and methods for the treatment of cancer
US20120251630A1 (en) 2011-03-29 2012-10-04 Marshall Edwards, Inc. Remission therapy of cancer with isoflavonoids

Also Published As

Publication number Publication date
CA2581316C (en) 2013-09-10
US20150352074A1 (en) 2015-12-10
AU2005287865B2 (en) 2012-02-16
MX2007003216A (es) 2008-03-10
EP1794141A4 (de) 2009-05-27
IL182034A0 (en) 2007-07-24
EP2407462B1 (de) 2014-07-30
EP2407462A1 (de) 2012-01-18
CA2581316A1 (en) 2006-03-30
EP1794141B1 (de) 2011-11-09
NO20072004L (no) 2007-05-30
WO2006032085A1 (en) 2006-03-30
CN101056868B (zh) 2012-05-02
US9138478B2 (en) 2015-09-22
US20160287555A1 (en) 2016-10-06
IL182034A (en) 2012-10-31
US9381186B2 (en) 2016-07-05
EP1794141A1 (de) 2007-06-13
US20120114766A1 (en) 2012-05-10
AU2005287865A1 (en) 2006-03-30
US8084628B2 (en) 2011-12-27
US7601855B2 (en) 2009-10-13
US8697891B2 (en) 2014-04-15
US20060074127A1 (en) 2006-04-06
US20090317490A1 (en) 2009-12-24
US20140170243A1 (en) 2014-06-19
CN101056868A (zh) 2007-10-17
NZ553834A (en) 2010-03-26

Similar Documents

Publication Publication Date Title
NO20072004L (no) Substituerte kromanderivater, medikamenter og anvendelse i terapi
ATE365703T1 (de) Substituierte 1,3-diphenylprop-2-en-1-on derivate,deren herstellung und anwendungen
CY1116373T1 (el) Φαρμακευτικα σκευασματα που περιεχουν μεθυλναλτρεξονη
DK1951729T3 (da) Oxygenbundne pyrimidinderivater
ATE380807T1 (de) N-oxid von n-phenyl-2-pyrimidinaminderivaten
CY1108592T1 (el) Διϋδροτετραβεναζινες και φαρμακευτικες συνθεσεις που τις περιεχουν
ATE472551T1 (de) Tocopherolmodifizierte therapeutische arzneimittelverbindung
BRPI0410913A (pt) benzotiofenos substituìdos com cicloalquil e heterocicloalquil como agentes terapêuticos
IL163090A (en) Nicotinamide derivates, pharmaceutical compositions comprising them and their use for manufacture of medicaments useful as p38 inhibitors
ECSP067095A (es) Compuestos y metodos para el tratamiento de dislipidemia
DE602006013622D1 (de) Steroids und anwendungen davon
DK1432402T3 (da) Sammensætning til tilförsel af lægemiddelkombinationer
JO2721B1 (en) Derivatives of artemisia plant and its preparations and therapeutic applications
BRPI0511874A (pt) derivados da pirrolopiridina
UY29036A1 (es) Derivados de oxopiperidina, su preparacion y su aplicacion en terapeutica
MX2007007027A (es) Derivados piperazinilpiridina como agentes anti-obesidad.
ATE545644T1 (de) Benzimidazolderivate, diese enthaltende zusammensetzungen, herstellung davon und anwendungen davon i
WO2006097617A3 (fr) Nouveaux derives dihydropyrimidines et leur utilisation comme agents anti-cancereux
WO2004026319A3 (en) Pharmaceutical compositions increasing camp useful for the treatment of cancers
WO2008036067A3 (en) Thiazolidinone amides, thiazolidine carboxylic acid amides, and serine amides, including polyamine conjugates thereof, as selective anti-cancer agents
WO2006132947A3 (en) 3-acyl coumarins, thiochromones and quinolones and therapeutic uses thereof
ATE424196T1 (de) Pharmazeutische zusammensetzungen mit platin- komplexen mit sekundären xanthaten und ihre therapeutischen anwendungen
WO2005097757A3 (en) Nucleoside derivatives and therapeutic use thereof
WO2010080415A3 (en) Substituted afpo (6-aryl-4h-furo[3,2-c]pyran-4-one) derivatives as anti-cancer agents
ATE508750T1 (de) Derivate von vitamin d und ihre verwendung in der therapie